Recent Announcements

FOR IMMEDIATE RELEASE

Sermo Has Tomorrow’s Hot Healthcare Topics – Today

Online Physician Community Captures Advance Trends from the Front-Lines of Medicine

Cambridge, MA – August 9, 2007 – With federal advisors recently determining that the diabetes pill Avandia should remain on the market, but now carry stricter warnings, many doctors are now faced with determining whether they should still prescribe the medication for their patients. Doctors on Sermo, however, have been debating the risks vs. benefits of Avandia since the drug’s safety was first called into question in May and have been exchanging insights from their practices on when it should be used — and when not. With more than 20,000 physicians nationwide, Sermo has become the “go-to” medical community for doctors to ask and answer questions of each other, build consensus around the latest medical trends, and exchange view points about drugs, devices and treatment options. This real-time collaboration has led to the forecast of health and medical trends before they hit the market and the consumer mainstream.

The topics that Sermo physicians are debating today are examples of what the healthcare industry, consumers and the nightly news could be talking about — and the investment community could be trading on — tomorrow.

“The collective experience of the Sermo community fosters the real-time sharing of front-line insight on breaking medical issues,” said Michael Tomblyn, MD. “This immediate exchange of information allows us to discuss and interpret the significance of topics more quickly than before. That is the Sermo edge.”

In recent weeks some of the most hotly debated topics on Sermo have included:

• Avandia: How will you react?


• Should pharmacists have the right to refuse to fill an RX?


• How are nurse practitioners impacting the practice of medicine?


• What are the risks and benefits of continuous contraceptive pills?


• Does fish oil added to statin therapy reduce the risk of heart attacks?


• What atypical antipsychotics have you used with the elderly?


• What are the risks of statins in pregnancy?


• Restless legs in children


• Seizures with theophylline toxicity


• The Physician Shortage and Universal Coverage


• Sliding scale insulin obsolete?


• Frivolous lawsuits


• Are drugs for dementia (donepezil, galantamine, and rivastigmine) effective?


• Informing families about antidepressant use in children


• Accelerated Approval at the FDA - Dead or Alive?

Sermo (http://www.sermo.com), the fastest growing online community created by physicians, for physicians, is growing at a rate of more than 600 new physicians per week and recently partnered with the American Medical Association (AMA) to improve medical practice, physician advocacy, and patient care. This agreement showcases just how powerful the information generated and shared on Sermo is to the medical community and the impact it can have on policies that affect change in healthcare.

About Sermo
Launched in September 2006, Sermo is already the largest online physician community, ever. Sermo’s Web-based platform provides a medium for physicians to aggregate observations from daily practice then — rapidly and in large numbers — challenge or corroborate each other’s opinions, accelerating the discovery of emerging trends and providing new insights into medications, devices and treatments. On Sermo, physicians exchange knowledge with each other the minute it is learned and gain potentially life saving insights from colleagues as they happen instead of waiting to read about them in conventional media sources. Sermo harnesses the power of collective wisdom and enables physicians to discuss new clinical findings, report unusual events, and work together to improve patient care in a way never before possible. Through its unique business model, Sermo is free to physicians and has no advertising or promotion. Based on a system of information arbitrage, Sermo allows healthcare organizations, financial services firms and industry analysts to access the community’s collective knowledge on a subscription basis.

Press Contacts:

Julie Blake
PerkettPR for Sermo
Phone: (781)-344-4131
E-mail: sermo@perkettpr.com